Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
XP Quote, Financials, Valuation and Earnings
Last price:
$18.12
Seasonality move
:
-0.41%
Day range:
$18.02 - $18.36
52-week range:
$10.82 - $20.64
Dividend yield:
3.56%
P/E ratio:
11.83x
P/S ratio:
7.46x
P/B ratio:
2.64x
Volume:
5.1M
Avg. volume:
5.5M
1-year change:
-2.25%
Market cap:
$9.6B
Revenue:
$1.4B
EPS (TTM):
$1.55
Analysts' Opinion
-
Consensus RatingXP has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $22.38, XP has an estimated upside of 22.44% from its current price of $18.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.73 representing -2.45% downside risk from its current price of $18.28.
Fair Value
-
According to the consensus of 8 analysts, XP has 22.44% upside to fair value with a price target of $22.38 per share.
XP vs. S&P 500
-
Over the past 5 trading days, XP has underperformed the S&P 500 by -4.8% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
XP does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
XP revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter XP reported revenues of $281.4M.
Earnings Growth
-
XP has grown year-over-year earnings for 1 quarter straight. In the most recent quarter XP reported earnings per share of $0.39.
Enterprise value:
7.3B
EV / Invested capital:
--
Price / LTM sales:
7.46x
EV / EBIT:
6.91x
EV / Revenue:
5.50x
PEG ratio (5yr expected):
9.23x
EV / Free cash flow:
3.26x
Price / Operating cash flow:
4.43x
Enterprise value / EBITDA:
6.60x
Gross Profit (TTM):
$365M
Return On Assets:
1.48%
Net Income Margin (TTM):
63.11%
Return On Equity:
22.7%
Return On Invested Capital:
5.46%
Operating Margin:
-77.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.4B | $1.3B | $328M | $281.4M | |
| Gross Profit | $277.3M | $351M | $365M | $34.2M | $14.5M | |
| Operating Income | -$671.7M | -$852.9M | -$711.3M | -$237M | -$216.9M | |
| EBITDA | $798.7M | $1B | $1.1B | $270.2M | $258.3M | |
| Diluted EPS | $1.21 | $1.53 | $1.55 | $0.37 | $0.39 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7B | $13B | $14.4B | $26.6B | $23.6B | |
| Total Assets | $21.1B | $34.2B | $38.2B | $55.6B | $60.7B | |
| Current Liabilities | $11.9B | $16.8B | $15.7B | $25.7B | $30B | |
| Total Liabilities | $19.1B | $30.9B | $34.8B | $51.5B | $57.1B | |
| Total Equity | $2B | $3.3B | $3.3B | $4.1B | $3.7B | |
| Total Debt | $7.8B | $5.4B | $5.4B | $10.2B | $10B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $798.3M | $293.2M | $2.3B | -$675.8M | -$449.3M | |
| Cash From Investing | -$46.3M | -$38.6M | -$192.2M | -$144.9M | -$26.2M | |
| Cash From Financing | -$189.6M | -$737.8M | -$1B | -$12.9M | $25.5M | |
| Free Cash Flow | $774.3M | $246.4M | $2.2B | -$685.3M | -$461.7M | |
XP
Sector
Market Cap
$9.6B
$627.9M
Price % of 52-Week High
88.57%
89.42%
Dividend Yield
3.56%
1.97%
Shareholder Yield
20.45%
4.06%
1-Year Price Total Return
-2.25%
7.77%
Beta (5-Year)
1.155
0.585
Dividend yield:
3.56%
Annualized payout:
$0.65
Payout ratio:
45.15%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$18.67
200-day SMA
Buy
Level
$15.87
Bollinger Bands (100)
Buy
Level
14.36 - 19.18
Chaikin Money Flow
Sell
Level
-8.9M
20-day SMA
Sell
Level
$19.25
Relative Strength Index (RSI14)
Sell
Level
39.61
ADX Line
Sell
Level
39.99
Williams %R
Buy
Level
-83.871
50-day SMA
Sell
Level
$18.97
MACD (12, 26)
Buy
Level
5.00
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-12.8M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.3518)
Buy
Beneish M-Score
(Annual)
Level (-2.4857)
Sell
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.833)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
Stock Forecast FAQ
In the current month, XP has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The XP average analyst price target in the past 3 months is $22.38.
-
Where Will XP Stock Be In 1 Year?
According to analysts, the consensus estimate is that XP share price will rise to $22.38 per share over the next 12 months.
-
What Do Analysts Say About XP?
Analysts are divided on their view about XP share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that XP is a Sell and believe this share price will drop from its current level to $18.73.
-
What Is XP's Price Target?
The price target for XP over the next 1-year time period is forecast to be $22.38 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is XP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for XP is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of XP?
You can purchase shares of XP via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase XP shares.
-
What Is The XP Share Price Today?
XP was last trading at $18.12 per share. This represents the most recent stock quote for XP. Yesterday, XP closed at $18.28 per share.
-
How To Buy XP Stock Online?
In order to purchase XP stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
